Market Capitalization (Millions $) |
122 |
Shares
Outstanding (Millions) |
71 |
Employees |
77 |
Revenues (TTM) (Millions $) |
- |
Net Income (TTM) (Millions $) |
-153 |
Cash Flow (TTM) (Millions $) |
5 |
Capital Exp. (TTM) (Millions $) |
0 |
Ventyx Biosciences Inc
Ventyx Biosciences Inc. is a pharmaceutical company focused on the development of new treatments for a range of diseases including cancer, infectious diseases, and autoimmune disorders. The company was founded in 2013 and is headquartered in San Diego, California.
Ventyx Biosciences specializes in the development of innovative drugs that target specific molecular pathways involved in disease progression. The company has a strong research and development pipeline that includes both small molecule drugs and biologics.
One of the key areas of focus for Ventyx Biosciences is the development of drugs that target the PI3K/AKT/mTOR pathway, which is involved in a variety of diseases including cancer, cardiovascular disease, and neurodegeneration. The company has several candidates in preclinical and clinical development targeting this pathway, including VTX-01, which is being developed for the treatment of solid tumors.
In addition to its work on the PI3K/AKT/mTOR pathway, Ventyx Biosciences is also developing drugs that target the NF-kB signaling pathway, which is involved in inflammation and immune responses. The company's lead candidate in this area is VTX-02, which is being developed for the treatment of autoimmune and inflammatory diseases such as rheumatoid arthritis and psoriasis.
Ventyx Biosciences has a strong team of experienced scientists and executives with a track record of success in drug development. The company has also established collaborations with leading academic institutions and pharmaceutical companies to accelerate its research and development efforts.
Overall, Ventyx Biosciences is a promising biotech company with a strong pipeline of innovative drugs targeting diverse disease areas. The company is well-positioned to make a significant impact on the pharmaceutical industry in the coming years.
Company Address: 12790 El Camino Real San Diego 92130 CA
Company Phone Number: 593-4832 Stock Exchange / Ticker: NASDAQ VTYX
|